Originally developed to treat type 2 diabetes, GLP-1 injections have shown remarkable efficacy in weight management and have been approved for this use in various formulations
When food stays in your stomach longer, you feel full for a more extended period
Knowing your genetic context supports a more informed discussion with your provider about dose selection and tolerance expectations
Because FXIa shares similar biochemical properties with immunoglobulin, it can be difficult to remove through standard purification processes
GLP-1 helps control blood sugar in type 2 diabetes by increasing insulin when needed, reducing glucose production in the liver, slowing digestion, and decreasing appetite
Research and future developments The promising results from the phase 2 trial of retatrutide have paved the way for further investigation in larger, phase 3 clinical trials